| Filed On | Filing |
|---|---|
| 16 Oct 2026 | SCHEDULE 13D/A |
| 22 Sep 2026 | SCHEDULE 13D/A |
| 04 Sep 2026 |
Form 4: Simon Josh, Director
Sold 181,893 shares ($1.05M) |
| 03 Sep 2026 |
Form 4: Simon Josh, Director
Received 333,333 shares by exercise or conversion |
| 03 Sep 2026 |
Form 4: Le Pendeven Yves, CFO
Sold 6,862 shares ($48.1K) · Sold 35,907 shares ($234K) |
| 03 Sep 2026 | 144/A |
| 02 Sep 2026 | 144 |
| 01 Sep 2026 | 144 |
| 28 Aug 2026 |
Form 4: Le Pendeven Yves, CFO
Sold 4,000 shares ($28K) |
| 26 Aug 2026 |
Form 4: Denson Charles D, Director
Bought 72,992 shares ($500K) |
| 13 Aug 2026 |
Form 4: Shah Husnal, Chief Product Officer
Sold 200 shares ($1.2K) · Sold 8,800 shares ($52.3K) |
| 12 Aug 2026 | 144 |
| 11 Aug 2026 |
Form 4: Le Pendeven Yves, CFO
Sold 13,138 shares ($92K) · Received 2,950 shares by exercise or conversion · Sold 1,117 shares ($6.7K) |
| 07 Aug 2026 | 144 |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 28 Jul 2026 | SCHEDULE 13G |
| 18 Jun 2026 | SCHEDULE 13D/A |
| 16 Jun 2026 |
Form 4: Denson Charles D, Director
Received 17,419 shares by exercise or conversion |
| 16 Jun 2026 |
Form 4: Levy Sarah Kirshbaum, Director
Received 17,419 shares by exercise or conversion |
Loading...